Scrip Regulatory Affairs
UK regulator highlights EU post-market surveillance failings
19 May 2010
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- UK consults on transposing EU pharmacovigilance rules into national law
- EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
- Calls for delay of EU medtech labelling decision as concerns continue
- UK PIP report largely vindicates EU medtech system but highlights need for improvements
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
